30 Technology
  • Company
    • Leadership Team
    • 30 Ecosystem
  • Careers
  • News
  • Contact
Select Page

Sitemap

Authors

  • 30 Technology
  • Brett Worth

Pages

  • Careers
  • Contact
  • Cookies
  • Data Protection
  • Ecosystem
  • Home
  • Leadership Team
  • News
  • Privacy Notice

Sitemap

  • Careers

    • DEVELOPMENT ANALYST, TECHNICAL OPERATIONS
    • ADMINISTRATIVE SUPPORT/LABORATORY TECHNICIAN
    • PRINCIPAL SCIENTIST, TECHNICAL OPERATIONS
  • News

    • 30 Technology enters into a strategic Licencing Agreement to develop new treatments for multi-drug resistant tuberculosis
    • 30 Technology launches a critical clinical trial of RESP301 in cystic fibrosis patients with serious lung infections
    • Thirty Respiratory receives approval for multicentre post-exposure clinical trial of RESP301 to prevent transmission of COVID-19 in the community
    • 30 Technology gets the go-ahead for multicentre clinical trial (CORVIS) in the UK of RESP301 in patients with COPD and viral exacerbations, including COVID-19
    • 30 Technology announces first patients enrolled in UK clinical trial (NOCoV2) for the treatment of COVID-19
    • Thirty Respiratory gets Regulatory Approval to start international, open-label, randomised, multi-centre Phase 2/3 trial of RESP301 in patients hospitalised with COVID-19

30 TECHNOLOGY Therapeutic Nitric Oxide

  • PRIVACY NOTICE
  • COOKIES
  • DATA PROTECTION
  • SITEMAP

Innovation Centre

Innovation Centre
141 Park Drive,
Milton Park OX14 4SE
United Kingdom

Registered Office

Thirty Holdings Limited
1 Red Place
London W1K 6PL
United Kingdom

Registered in England
No.11614943

Contact

contact@30.technology
+44 (0) 1235 431 201

© 30 Technology 2022
All Rights Reserved

Designed by Elegant Themes | Powered by WordPress